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Introduction
Toll-Like Receptors (TLRs) and Defensins play a crucial
role in host’s innate immune response. Genetic variations
in Defensins and TLRs may affect host-virus interactions
and impact HIV1 disease progression, particularly in
infants who acquire immune infection when adaptive
immune response is still under development.
Methods
The study was performed in 95 perinatally HIV1 infected
children followed since birth. The endpoint was the onset
of disease (stage C) or initiation of highly active antiretro-
viral therapy. The median (interquartile) followup from
birth to endpoint was 87 (46-134) months. Single nucleo-
tide polymorphisms (SNPs) on Beta-defensin1 (DEFB1
-44C>G;-52G>A), and TLR9 (1174G>A;1635A>G) genes
were identified with TaqMan allelic discrimination assay.
The probability of acquiring disease was calculated with
Kaplan-Meier method. Hazard ratios and their 95% confi-
dence interval (95% CI) based on the Cox proportional
hazards model were estimated to test the association
between genotypes, haplotypes and risk of stage C.
Results
TLR9 1635AG genotype was associated with rapid dis-
ease progression with both KaplanMeier (p=0.008) and
Cox analysis (p=0.009), while DEFB1 -44CG genotype
was associated with slower disease progression with both
KaplanMeier (p=0.020) and Cox analysis (p=0.024).
Notably, TLR9 [G;G] haplotype, previously associated
with a higher risk of mother-to-child transmission of
HIV1 (MTCT), was also found to be associated with
rapid disease progression (p=0.033). In addition, DEFB1
[G;G] haplotype, found to be protective against MTCT,
was associated (p=0.016) with a better clinical outcome
in HIV1 infected children.
Conclusions
Overall, these findings support the role of innate immunity
in pediatric HIV1 pathogenesis. Specific SNPs in DEFB1
and TLR9 genes may affect the functional ability of their
encoded proteins to modulate innate immunity, thus con-
tributing to the variability of clinical outcome in HIV1
infected children.
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